Clinical Research Directory
Browse clinical research sites, groups, and studies.
The Jinling Cohort
Sponsor: Nanjing Shihejiyin Technology, Inc.
Summary
The Jinling Cohort is a prospective, multicenter cohort study in which 15,000 eligible individuals aged 45-75 in Nanjing China will be enrolled.
Official title: A Prospective, Multicenter Cohort Study of the Multi-omics Liquid Biopsy MCED Test MERCURY in an Average Risk Chinese Population
Key Details
Gender
All
Age Range
45 Years - 75 Years
Study Type
OBSERVATIONAL
Enrollment
15000
Start Date
2022-06-15
Completion Date
2027-05-15
Last Updated
2023-08-25
Healthy Volunteers
Yes
Interventions
MERCURY test, health questionnaires and annual routine physical exams
Each participant will undergo peripheral blood collection for MERCURY test, health questionnaires and annual routine physical exams once a year for three consecutive years, then followed up two additional years.
Locations (2)
Nanjing Jiangbei People's Hospital
Nanjing, Jiangsu, China
The Fourth Affiliated Hospital of Nanjing Medical University
Nanjing, Jiangsu, China